Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomeAnnouncementsAnnouncement Detail

Public Comment on Draft Recommendation Statement and Draft Evidence Summaries: Aspirin to Prevent Cardiovascular Disease and Cancer

The U.S. Preventive Services Task Force posted today a draft recommendation statement and draft evidence summaries on aspirin to prevent cardiovascular disease and cancer. These are available for review and public comment from September 15, 2015 through October 12, 2015. To review the draft recommendation statement and draft evidence summaries and submit comments, go to http://www.uspreventiveservicestaskforce.org/Page/Name/us-preventive-services-task-force-opportunities-for-public-comment.

Current as of: December 2017

Internet Citation: Public Comment on Draft Recommendation Statement and Draft Evidence Summaries: Aspirin to Prevent Cardiovascular Disease and Cancer. U.S. Preventive Services Task Force. September 2015.
https://www.uspreventiveservicestaskforce.org/Announcements/News/Item/public-comment-on-draft-recommendation-statement-and-draft-evidence-summaries-aspirin-to-prevent-cardiovascular-disease-and-cancer

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857